Literature DB >> 25190801

Essential role of the zinc finger transcription factor Casz1 for mammalian cardiac morphogenesis and development.

Zhihui Liu1, Wenling Li2, Xuefei Ma3, Nancy Ding4, Francesco Spallotta5, Eileen Southon6, Lino Tessarollo6, Carlo Gaetano5, Yoh-Suke Mukouyama2, Carol J Thiele7.   

Abstract

Chromosome 1p36 deletion syndrome is one of the most common terminal deletions observed in humans and is related to congenital heart disease (CHD). However, the 1p36 genes that contribute to heart disease have not been clearly delineated. Human CASZ1 gene localizes to 1p36 and encodes a zinc finger transcription factor. Casz1 is required for Xenopus heart ventral midline progenitor cell differentiation. Whether Casz1 plays a role during mammalian heart development is unknown. Our aim is to determine 1p36 gene CASZ1 function at regulating heart development in mammals. We generated a Casz1 knock-out mouse using Casz1-trapped embryonic stem cells. Casz1 deletion in mice resulted in abnormal heart development including hypoplasia of myocardium, ventricular septal defect, and disorganized morphology. Hypoplasia of myocardium was caused by decreased cardiomyocyte proliferation. Comparative genome-wide RNA transcriptome analysis of Casz1 depleted embryonic hearts identifies abnormal expression of genes that are critical for muscular system development and function, such as muscle contraction genes TNNI2, TNNT1, and CKM; contractile fiber gene ACTA1; and cardiac arrhythmia associated ion channel coding genes ABCC9 and CACNA1D. The transcriptional regulation of some of these genes by Casz1 was also found in cellular models. Our results showed that loss of Casz1 during mouse development led to heart defect including cardiac noncompaction and ventricular septal defect, which phenocopies 1p36 deletion syndrome related CHD. This suggests that CASZ1 is a novel 1p36 CHD gene and that the abnormal expression of cardiac morphogenesis and contraction genes induced by loss of Casz1 contributes to the heart defect.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cardiac Development; Cardiovascular; Development; Heart Development; Heart Failure

Mesh:

Substances:

Year:  2014        PMID: 25190801      PMCID: PMC4207993          DOI: 10.1074/jbc.M114.570416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Cell adhesion in embryo morphogenesis.

Authors:  Vanessa Barone; Carl-Philipp Heisenberg
Journal:  Curr Opin Cell Biol       Date:  2011-12-13       Impact factor: 8.382

Review 2.  p63/p73 in the control of cell cycle and cell death.

Authors:  N Allocati; C Di Ilio; V De Laurenzi
Journal:  Exp Cell Res       Date:  2012-02-03       Impact factor: 3.905

Review 3.  Genetics of ion-channel disorders.

Authors:  Marina Cerrone; Carlo Napolitano; Silvia G Priori
Journal:  Curr Opin Cardiol       Date:  2012-05       Impact factor: 2.161

Review 4.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

5.  Nemaline myopathy and non-fatal hypertrophic cardiomyopathy caused by a novel ACTA1 E239K mutation.

Authors:  Sun-Young Kim; Young-Eun Park; Hyang-Sook Kim; Chang-Hoon Lee; Dong Heon Yang; Dae-Seong Kim
Journal:  J Neurol Sci       Date:  2011-05-13       Impact factor: 3.181

Review 6.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

Review 7.  [Congenital myopathies - skeletal muscle diseases related to disorder of actin filament structure and functions].

Authors:  Katarzyna Robaszkiewicz; Joanna Moraczewska
Journal:  Postepy Hig Med Dosw (Online)       Date:  2011-06-14       Impact factor: 0.270

Review 8.  Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Nat Rev Cardiol       Date:  2012-01-31       Impact factor: 32.419

9.  Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression.

Authors:  Ryan A Virden; Carol J Thiele; Zhihui Liu
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

Review 10.  1p36 tumor suppression--a matter of dosage?

Authors:  Kai-Oliver Henrich; Manfred Schwab; Frank Westermann
Journal:  Cancer Res       Date:  2012-11-20       Impact factor: 12.701

View more
  32 in total

Review 1.  Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors.

Authors:  Josef Finsterer; Claudia Stöllberger; Jeffrey A Towbin
Journal:  Nat Rev Cardiol       Date:  2017-01-12       Impact factor: 32.419

2.  Electrically Driven Microengineered Bioinspired Soft Robots.

Authors:  Su Ryon Shin; Bianca Migliori; Beatrice Miccoli; Yi-Chen Li; Pooria Mostafalu; Jungmok Seo; Serena Mandla; Alessandro Enrico; Silvia Antona; Ram Sabarish; Ting Zheng; Lorenzo Pirrami; Kaizhen Zhang; Yu Shrike Zhang; Kai-Tak Wan; Danilo Demarchi; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  Adv Mater       Date:  2018-01-11       Impact factor: 30.849

Review 3.  Zinc and Zinc Transporters: Novel Regulators of Ventricular Myocardial Development.

Authors:  Wen Lin; Deqiang Li
Journal:  Pediatr Cardiol       Date:  2018-03-13       Impact factor: 1.655

4.  A conserved regulatory logic controls temporal identity in mouse neural progenitors.

Authors:  Pierre Mattar; Johan Ericson; Seth Blackshaw; Michel Cayouette
Journal:  Neuron       Date:  2015-02-04       Impact factor: 17.173

5.  Casz1 is required for cardiomyocyte G1-to-S phase progression during mammalian cardiac development.

Authors:  Kerry M Dorr; Nirav M Amin; Lauren M Kuchenbrod; Hanna Labiner; Marta S Charpentier; Larysa H Pevny; Andy Wessels; Frank L Conlon
Journal:  Development       Date:  2015-05-07       Impact factor: 6.868

6.  Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC).

Authors:  Ying Liu; Hanying Chen; Weinian Shou
Journal:  Pediatr Cardiol       Date:  2018-05-15       Impact factor: 1.655

7.  CASZ1 is a novel promoter of metastasis in ovarian cancer.

Authors:  Yi-Ying Wu; Chia-Lin Chang; Yuan-Jhe Chuang; Jia-En Wu; Chia-Hao Tung; Yeong-Chang Chen; Yuh-Ling Chen; Tse-Ming Hong; Keng-Fu Hsu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

8.  Anacardic acid and thyroid hormone enhance cardiomyocytes production from undifferentiated mouse ES cells along functionally distinct pathways.

Authors:  Agnese Re; Simona Nanni; Aurora Aiello; Serena Granata; Claudia Colussi; Giulia Campostrini; Francesco Spallotta; Stefania Mattiussi; Valentina Pantisano; Carmen D'Angelo; Annamaria Biroccio; Alessandra Rossini; Andrea Barbuti; Dario DiFrancesco; Francesco Trimarchi; Alfredo Pontecorvi; Carlo Gaetano; Antonella Farsetti
Journal:  Endocrine       Date:  2015-11-07       Impact factor: 3.633

9.  Causal Genetic Variants in Stillbirth.

Authors:  Kate E Stanley; Jessica Giordano; Vanessa Thorsten; Christie Buchovecky; Amanda Thomas; Mythily Ganapathi; Jun Liao; Avinash V Dharmadhikari; Anya Revah-Politi; Michelle Ernst; Natalie Lippa; Halie Holmes; Gundula Povysil; Joseph Hostyk; Corette B Parker; Robert Goldenberg; George R Saade; Donald J Dudley; Halit Pinar; Carol Hogue; Uma M Reddy; Robert M Silver; Vimla Aggarwal; Andrew S Allen; Ronald J Wapner; David B Goldstein
Journal:  N Engl J Med       Date:  2020-08-12       Impact factor: 91.245

Review 10.  Genetics of Cardiac Developmental Disorders: Cardiomyocyte Proliferation and Growth and Relevance to Heart Failure.

Authors:  Lisa Wilsbacher; Elizabeth M McNally
Journal:  Annu Rev Pathol       Date:  2016-02-24       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.